A detailed history of Corton Capital Inc. transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Corton Capital Inc. holds 2,443 shares of TMDX stock, worth $215,863. This represents 0.19% of its overall portfolio holdings.

Number of Shares
2,443
Previous 2,500 2.28%
Holding current value
$215,863
Previous $376,000 1.86%
% of portfolio
0.19%
Previous 0.21%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$135.68 - $176.11 $7,733 - $10,038
-57 Reduced 2.28%
2,443 $383,000
Q2 2024

Aug 14, 2024

SELL
$72.62 - $150.62 $36,818 - $76,364
-507 Reduced 16.86%
2,500 $376,000
Q1 2024

May 15, 2024

BUY
$70.86 - $89.93 $24,517 - $31,115
346 Added 13.0%
3,007 $222,000
Q4 2023

Feb 14, 2024

BUY
$36.74 - $81.08 $97,765 - $215,753
2,661 New
2,661 $210,000
Q2 2023

Aug 14, 2023

BUY
$66.23 - $88.73 $307,572 - $412,062
4,644 New
4,644 $390,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.81B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Corton Capital Inc. Portfolio

Follow Corton Capital Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corton Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Corton Capital Inc. with notifications on news.